Highlights Zhejiang Xianju Pharmaceutical Co.,Ltd.

Equities

002332

CNE100000K64

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 19/06/2024 BST			5-day change	1st Jan Change
11.58 ^CNY	+1.22%		+0.52%	-9.32%

04-24	Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Xianju Pharma to Invest 33 Million Yuan in Local Drug R&D Firm	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces 2023 Final Profit Distribution on A Shares, Payable on 05 June 2024	05-30	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2023	05-21	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Proposes Final Dividend for the Year 2023	04-24	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Xianju Pharma to Invest 33 Million Yuan in Local Drug R&D Firm	12-27	MT
Zhejiang Xianju Pharmaceutical's Flumazenil Injection Chosen for China's Centralized Bid	11-08	MT
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23/08/23	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 02 June 2023	29/05/23	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2022	24/05/23	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Proposes Final Dividend for 2022	26/04/23	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23	CI
Zhejiang Xianju Pharma’s Abortion Tablet Passes Consistency Evaluation	10/03/23	MT
Zhejiang Xianju Pharma Logs 20.4% Jump in 2022 Profit	24/02/23	MT
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23/02/23	CI
Ningbo Linghan Enterprise Management Partnership Enterprise (Limited Partnership) entered into equity transaction contract to acquire 14.60% stake in Hangzhou Weisibo Medical Technology Co., Ltd. from Zhejiang Xianju Pharmaceutical Co.,Ltd. for CNY 8 million.	28/12/22	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on June 8, 2022	31/05/22	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves 2021 Profit Distribution Plan	13/05/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Zhejiang Xianju Pharmaceutical Co.,Ltd.

Equities

002332

CNE100000K64

Highlights

Filters